bacteriophage

Phico Therapeutics receives funding from CARB-X towards the development of engineered bacteriophage with SASP gene targeting Pseudomonas aeruginosa.

BiomX updates on pipeline products against Cystic fibrosis (CF), Atopic dermatitis (AD), Inflammatory bowel disease (IBD), and Primary sclerosing cholangitis (PSC), as well as a treatment against Acne-prone skin and Colorectal cancer.

Cytophage announced the beginning of animal testing of their throat and nasal phage spray that targets the COVID-19 virus.

Skin care products with bacteriophages are currently being developed by several companies dealing with personal care products, in order to address commonly shared skin issues.

TechnoPhage announced the beginning of Phase I/IIa study of TP-102 phage therapy to treat Diabetic Foot Infections (DPI).

Kisaco Research Phage Futures Congress 2021 – Virtual summit. The summit will be held from the 24th to the 26th of February 2021.

Synthetic bacteriophages with shortened genome created successfully by scientists from CEB – Centre of Biological Engineering, Braga in Portugal.

Microbiome Movement Bacteriophage Therapy Summit 2021 – Digital event. The summit will be from the 23rd to the 25th of March 2021.

Research shows an opportunity in using a combination of bacteriophages with antibiotics against superbugs.

MarketsandMarkets Next Gen Microbiome and Probiotics 2021 will be held as a virtual conference. The event will be on the 25th and 26th of February 2021.